Valuation: Inter Pharma

Market Cap 292.99Cr 8.76Cr 7.68Cr 7.12Cr 6.55Cr 12Cr 838.62Cr 13Cr 85Cr 33Cr 411.83Cr 33Cr 32Cr 1.42TCr P/E 2024
52.3x
P/E 2025 22.8x
Enterprise Value 304.92Cr 9.12Cr 8Cr 7.41Cr 6.82Cr 13Cr 872.76Cr 13Cr 88Cr 35Cr 428.59Cr 34Cr 33Cr 1.48TCr EV / Sales 2024
1.13x
EV / Sales 2025 1.31x
Free-Float
-
Yield 2024 *
-
Yield 2025 1.59%
11/05 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02/03 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02/03 Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 CI
12/11 Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients. CI
12/11 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/25/14 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/25/13 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/25/16 Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal MT
16/25/16 Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited CI
01/25/01 Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation CI
25/25/25 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25/25/25 Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024 CI
14/24/14 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
1 day+0.41%
1 week+7.08%
Current month+8.52%
1 month+8.52%
3 months+18.63%
6 months+10.00%
Current year+5.22%
1 week 4.54
Extreme 4.54
4.94
1 month 4.32
Extreme 4.32
4.94
Current year 3.68
Extreme 3.68
4.94
1 year 3.14
Extreme 3.14
4.94
3 years 2.02
Extreme 2.02
7.88
5 years 2.02
Extreme 2.02
14.95
10 years 1.62
Extreme 1.6176
15.14
Manager TitleAgeSince
Chief Executive Officer 56 01/02/2014
Director of Finance/CFO 56 23/06/2023
Compliance Officer 54 -
Director TitleAgeSince
Director/Board Member 51 14/06/2017
Director/Board Member 64 01/08/2020
Director/Board Member 56 01/02/2014
Date Insider Type Main position Quantity % Market Cap.
21/05Buy

Chief Executive Officer

60,000 0.0099%
21/05Buy

Chief Executive Officer

60,000 0.0099%
20/05Buy

Chief Executive Officer

22,600 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%+7.08%+47.56%-32.78% 8.76Cr
-0.56%-1.52%+49.04%+171.88% 1,05400Cr
+0.31%-0.60%+64.29%+62.31% 62TCr
-0.03%-2.65%+28.86%+85.64% 44TCr
-0.42%-3.00%+27.78%+21.42% 32TCr
-0.95%-2.71%+27.93%+45.20% 28TCr
-0.44%-12.64%+17.69%+21.54% 26TCr
-0.99%-1.76%-27.42%-39.50% 22TCr
-0.81%-1.63%+22.07%+58.33% 19TCr
+1.21%+1.38%+19.85%+71.29% 16TCr
Average -0.27%-0.82%+27.77%+46.53% 35.56TCr
Weighted average by Cap. -0.38%-1.68%+35.78%+83.50%

Financials

2024 2025
Net sales 191.19Cr 5.72Cr 5.02Cr 4.64Cr 4.27Cr 8.08Cr 547.26Cr 8.24Cr 55Cr 22Cr 268.75Cr 21Cr 21Cr 928.11Cr 221.41Cr 6.62Cr 5.81Cr 5.38Cr 4.95Cr 9.36Cr 633.73Cr 9.54Cr 64Cr 25Cr 311.21Cr 25Cr 24Cr 1.07TCr
Net income 3.73Cr 11.15L 10L 9L 8L 15.76L 11Cr 16.07L 1.08Cr 42.33L 5.24Cr 41.86L 40.95L 18Cr 12Cr 36.6L 32.1L 29.73L 27.36L 51.74L 35Cr 52.75L 3.54Cr 1.39Cr 17Cr 1.37Cr 1.34Cr 59Cr
Net Debt 21Cr 62.48L 54.8L 50.75L 46.7L 88.33L 60Cr 90.05L 6.05Cr 2.37Cr 29Cr 2.35Cr 2.29Cr 101.41Cr 12Cr 35.67L 31.29L 28.98L 26.67L 50.44L 34Cr 51.42L 3.45Cr 1.35Cr 17Cr 1.34Cr 1.31Cr 58Cr
Logo Inter Pharma
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Employees
-
Date Price Change Volume
13/26/13 THB 4.840 +0.41% 1,04,391
10/26/10 THB 4.820 -1.23% 4,95,377
09/26/09 THB 4.880 +1.24% 5,62,645
08/26/08 THB 4.820 +6.64% 30,93,352
07/26/07 THB 4.520 0.00% 2,35,390

Annual profits - Rate of surprise